Panagora Asset Management Inc Vaxart, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$5.64 - $23.33 $185,787 - $768,513	-32,941 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.68 - $8.85 $55,340 - $291,527	32,941 New	32,941 $292,000
Q1 2019 May 15, 2019	SELL	$1.5 - $2.34 $28,051 - $43,760	-18,701 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.88 - $5.25 $4,966 - $13,870	2,642 Added 16.45%	18,701 $35,000
Q3 2018 Nov 13, 2018	SELL	$2.42 - $3.29 $17,917 - $24,359	-7,404 Reduced 31.56%	16,059 $46,000
Q2 2018 Aug 14, 2018	BUY	$2.88 - $6.0 $63,167 - $131,598	21,933 Added 1433.53%	23,463 $71,000
Q1 2018 May 15, 2018	BUY	$4.95 - $9.02 $7,573 - $13,800	1,530 New	1,530 $8,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.